BSEBrawn Biotech LtdMinimalNeutral
Announced Sat, 30 May · 17:42 IST

Newspaper publication of Audited Financial Results for Quarter and Year ended 31.03.2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹20.75
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.4+5.3-5.1
Up moveDown movePending
AI summary

Brawn Biotech Ltd has published its audited financial results for Q4 and the financial year ended March 31, 2026, in Business Standard newspapers (English and Hindi editions) dated May 30, 2026. The results were taken on record by the Board of Directors at their meeting held on May 29, 2026. The company stated that the detailed financial results were filed with BSE under Regulation 33 of SEBI LODR Regulations, 2015, and the full format is available on the BSE and company websites. Note: This newspaper clipping contains multiple company financial publications bundled together; the actual financial numbers in the document belong to other companies (Rishi Techtex, Simbhaoli Sugars, SPL, Rallis India). Brawn Biotech's specific financial figures are not included in this filing.

Likely market impact

The filing confirms regulatory compliance with SEBI listing requirements for publishing quarterly and annual results in newspapers. However, the filing itself does not contain Brawn Biotech's actual financial numbers, limiting its immediate value for investors seeking performance data.